Qube Research & Technologies Ltd - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 380 filers reported holding VIKING THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$3,771,016
+595.6%
45,988
+57.9%
0.01%
+500.0%
Q4 2023$542,147
+330.3%
29,132
-36.9%
0.00%0.0%
Q3 2022$126,000
+65.8%
46,186
+75.5%
0.00%0.0%
Q2 2022$76,000
-11.6%
26,323
-8.2%
0.00%0.0%
Q1 2022$86,000
+68.6%
28,683
+159.1%
0.00%
Q4 2021$51,000
-19.0%
11,071
-0.8%
0.00%
-100.0%
Q4 2020$63,000
-50.0%
11,157
-48.3%
0.00%
-50.0%
Q3 2020$126,000
-55.6%
21,572
-45.2%
0.00%
-50.0%
Q2 2020$284,00039,3970.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders